Corcept Therapeutics Inc (CORT)
- Sector
- Pharmaceuticals
- Last price
- $72.77
- As of
Kresmion compiles this page from CORT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
CORCEPT THERAPEUTICS INC (CORT): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-03.
See the full CORT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CORT on one page. Preview it with sample data, then open it live with a free account.
Preview the CORT dossierActive events for CORT
- mediumEarnings above estimates
Q3-2026: Beat consensus by 24.7%, EPS $1.01 vs $0.8099 estimate
- mediumTrend spike
CORCEPT THERAPEUTICS INC search volume spiked +100 pts, unusual interest
- high13F: funds added
3 tracked funds increased CORT this 2026Q2, institutional consensus
- highInsider cluster: sales
3 insiders at CORT sold $4.9M this week
- high13F: funds reduced
3 tracked funds reduced CORT this 2026Q2, institutional consensus
FREE, NO ACCOUNT
Every event on CORT, as it fires
You are seeing 5 of 24 events recorded on CORT since 2026-05-31.
The five above landed across 5 days. The other 19 were recorded on 5 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
CORT positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 218352102 · 2026Q2 | $457.5M | 0.63% |
| D. E. Shaw & Co., Inc. FundCUSIP 218352102 · 2026Q2 | $76.8M | 0.05% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP 218352102 · 2026Q2 | $53M | 0.04% |
| MILLENNIUM MANAGEMENT LLC FundCUSIP 218352102 · 2026Q2 | $13.3M | 0.01% |
| CITADEL ADVISORS LLC FundCUSIP 218352102 · 2026Q2 | $9.5M | 0.01% |
| Bridgewater Associates, LP FundCUSIP 218352102 · 2026Q2 | $5M | 0.02% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CORT
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
More data on CORT
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CORT on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CORT in the last 180 days.
Upstream: SEC EDGAR filings for CORT
Kresmion, "CORCEPT THERAPEUTICS INC (CORT) institutional holdings and SEC filings", data as of 2026-11-05, https://kresmion.com/research/CORT. Upstream data: SEC EDGAR filings for CORT.
Link to this data (HTML):
<a href="https://kresmion.com/research/CORT">CORCEPT THERAPEUTICS INC (CORT) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CORT on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CORT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.